Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 1/31/2019 |
| Start Date: | December 1, 2017 |
| End Date: | November 30, 2019 |
| Contact: | Ryan C Gibbons, MD |
| Email: | ryan.gibbons@tuhs.temple.edu |
| Phone: | 610-613-7408 |
Arthrocentesis is the removal of synovial fluid for analysis of pathologic processes. Small &
medium joint arthrocentesis will be defined as the following joints: elbow, wrist, finger,
ankle and toe. Ultrasound (US) and landmark (LM) small & medium joint arthrocentesis are both
performed within the clinical setting. Both techniques are considered standard of care.
Selection of which technique to use is dependent upon the physician's preference. There is
currently limited data comparing the two methods. The investigators hope to determine if one
modality is more effective in terms of success rate, number of attempts, and time to complete
the procedure.
medium joint arthrocentesis will be defined as the following joints: elbow, wrist, finger,
ankle and toe. Ultrasound (US) and landmark (LM) small & medium joint arthrocentesis are both
performed within the clinical setting. Both techniques are considered standard of care.
Selection of which technique to use is dependent upon the physician's preference. There is
currently limited data comparing the two methods. The investigators hope to determine if one
modality is more effective in terms of success rate, number of attempts, and time to complete
the procedure.
Patients presenting to the Emergency Department who are 18 years old or older, who do not
belong to a vulnerable group, requiring small or medium joint arthrocentesis will be included
in this trial. The investigators will randomize each patient into LM vs US. Data collected
will include number of attempts to tap the joint, success rate, and time for procedure to be
completed. The arthrocentesis will be performed by PGY-3 residents only. A 21 gauge needle
will be used for the arthrocentesis.
belong to a vulnerable group, requiring small or medium joint arthrocentesis will be included
in this trial. The investigators will randomize each patient into LM vs US. Data collected
will include number of attempts to tap the joint, success rate, and time for procedure to be
completed. The arthrocentesis will be performed by PGY-3 residents only. A 21 gauge needle
will be used for the arthrocentesis.
Inclusion Criteria:
- All patients who require an arthrocentesis of a small and/or medium joint (defined
previously)
Exclusion Criteria:
- Coagulopathic patients
- Patients on anticoagulants
- Patients with cellulitis overlying the joint.
- Patients with artificial joints
- Adults Unable to Consent
- Vulnerable Populations
We found this trial at
1
site
3500 North Broad Street
Philadelphia, Pennsylvania 19140
Philadelphia, Pennsylvania 19140
Phone: 610-613-7408
Click here to add this to my saved trials
